About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
20 markets identified in PhRMA’s 2018 Special 301 submission are undermining the work of America’s biopharmaceutical innovators. To protect U.S. patents and intellectual property, America must enforce trade agreements and ensure fair access to overseas markets. Special 301 is designed to ensure that our trading partners provide fair access to their markets for IP-intensive U.S. industries.
Foreign Threats to American Intellectual Property image
Download
Resource
Intellectual Property
Foreign Threats to American Intellectual Property
Foreign Threats to American Intellectual Property image